Financing ·
Liminatus Pharma, Inc. entered into a warrant exercise inducement agreement allowing a holder to exercise 10,344,000…
LIMNLiminatus Pharma, Inc.
Liminatus Pharma, Inc. entered into a warrant exercise inducement agreement allowing a holder to exercise 10,344,000 existing warrants at a reduced price of $0.18 per share. In exchange, the company will issue up to 20,688,000 new warrants at an exercise price of $0.18 per share, resulting in approximately $1,861,920 in gross proceeds. The company intends to use these proceeds for working capital and general corporate purposes.